These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 17181588

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system.
    Larsson S, Sandgren P, Sjödin A, Vesterinen M, Gulliksson H.
    Transfusion; 2005 May; 45(5):743-51. PubMed ID: 15847664
    [Abstract] [Full Text] [Related]

  • 28. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
    Sandgren P, Callaert M, Shanwell A, Gulliksson H.
    Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
    [Abstract] [Full Text] [Related]

  • 29. Maintenance of in vitro properties of leukoreduced whole blood-derived pooled platelets after a 24-hour interruption of agitation.
    Vassallo RR, Wagner SJ, Einarson M, Nixon J, Ziegler D, Moroff G.
    Transfusion; 2009 Oct; 49(10):2131-5. PubMed ID: 19555418
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R, Fröhlich A, Mayaudon V, Lin L.
    J Clin Apher; 2004 Oct; 19(4):185-91. PubMed ID: 15597347
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system.
    Gulliksson H, Sjödin A, Sandgren P, Vesterinen M, Larsson S, Diedrich B.
    Transfus Apher Sci; 2003 Aug; 29(1):11-2. PubMed ID: 12877886
    [No Abstract] [Full Text] [Related]

  • 38. Exploratory in vitro study of red blood cell storage containers formulated with an alternative plasticizer.
    Dumont LJ, Baker S, Dumont DF, Herschel L, Waters S, Calcagni K, Sandford C, Radwanski K, Min K, David RM, Otter R.
    Transfusion; 2012 Jul; 52(7):1439-45. PubMed ID: 22211692
    [Abstract] [Full Text] [Related]

  • 39. Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate in patients receiving plateletpheresis concentrates.
    Buchta C, Bittner C, Heinzl H, Höcker P, Macher M, Mayerhofer M, Schmid R, Seger C, Dettke M.
    Transfusion; 2005 May; 45(5):798-802. PubMed ID: 15847671
    [Abstract] [Full Text] [Related]

  • 40. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J.
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.